CharlesISheltonDODFAPA

PubMed

• 7 citations
  Should we routinely add CRP to clozapine titrations? - Learning from three cases.
  Charles Shelton, Can-Jun Ruan, Aygün Ertuğrul, Robert O Cotes, Jose De Leon> ;Neuropsychopharmacologia Hungarica. 2022 Dec 1
• Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
  Jose de Leon, Georgios Schoretsanitis, Robert L Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Ce...> ;Pharmacopsychiatry. 2022 Mar 1
• 121 citations
  An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
  Jose de Leon, Georgios Schoretsanitis, Robert L Smith, Espen Molden, Anssi Solismaa, Niko Seppälä, Miloslav Kopeček, Patrik Švancer, Ismael Olmos, Carina Ricciardi, Ce...> ;Pharmacopsychiatry. 2022 Mar 1
• Proactive Modification to Clozapine Dose in a Patient With Pneumonia to Prevent Toxicity.
  Betsy McCollum, Paige K. Juettner, Charles I. Shelton> ;The Primary Care Companion for CNS Disorders. 2021 Jan 7
• 5 citations
  High Doses of Drugs Extensively Metabolized by CYP3A4 Were Needed to Reach Therapeutic Concentrations in Two Patients Taking Inducers
  Nitin Chopra, Can-Jun Ruan, Betsy McCollum, Judy Ognibene, Charles I. Shelton, Jose de Leon> ;Revista Colombiana De Psiquiatria. 2020 Apr 1
• 4 citations
  A retrospective analysis of the association between providing nicotine replacement therapy at admission and motivation to quit and nicotine withdrawal symptoms during ...
  Chizimuzo T.C. Okoli, Yazan D. Al-Mrayat, Charles I. Shelton, Milan Khara> ;Addictive Behaviors. 2018 Jun 7
• 1 citations
  Moria: An Unrecognized Frontal Lobe Symptom.
  Victoria C de Leon, John Bilbily, Charles I. Shelton, Jose de Leon> ;The Primary Care Companion for CNS Disorders. 2017 Aug 3
• 8 citations
  Factors Impacting the Selection of Antidepressant Treatment in Patients With Major Depressive Disorder at Risk for Nonadherence
  Charles I. Shelton> ;CNS Spectrums. 2009 Dec 1
• 25 citations
  Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
  Charles I. Shelton, Richard Entsuah, S Krishna Padmanabhan, Phillip E Vinall> ;International Clinical Psychopharmacology. 2005 Jul 1
• 22 citations
  Long-term management of major depressive disorder: are differences among antidepressant treatments meaningful?
  Charles I. Shelton> ;The Journal of Clinical Psychiatry. 2004 Dec 15
• 26 citations
  Diagnosis and Management of Anxiety Disorders
  Charles I. Shelton> ;The Journal of the American Osteopathic Association. 2004 Mar 1
• 14 citations
  Diagnosis and Management of Anxiety Disorders
  Charles I. Shelton> ;The Journal of the American Osteopathic Association. 2004 Mar 1
• Join now to see all